Abstract
Polatuzumab Vedotin Plus Bendamustine with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have